Stocks to Watch: FedEx, Oracle, Avon, Express Scripts – Wall Street Journal

FedEx posted weaker-than-expected quarterly profits, though sales grew more than expected.


Christopher Lee/Bloomberg News

Here are some of the companies with shares expected to trade actively in Tuesday’s session. Stock movements reflect premarket trading.

Facebook Inc.—Down 0.7%:


has been haggling with financial firms over its access to sensitive financial data for years, pressing companies for the ability to use customer data flowing through its Messenger platform for a range of purposes, including advertising.


—Up 0.3%: Google is making a major push into the auto industry, partnering with the Renault-Nissan-Mitsubishi Alliance to use the Android operating system to power media display, marking a major victory for the Silicon Valley tech giant.

Viking Therapeutics

—Up 120%: The biotech company reported positive results of a trial of a treatment for nonalcoholic fatty liver disease.

Netflix Inc.—Up 1.2%: Netflix tied with HBO for the most Emmy Awards with 23 each, highlighting the race for dominance in the rapidly changing television industry.

General Mills Inc.—Down 2%:

General Mills

posted sales growth but North America underperformed, with the food company’s sales declining 2.1% in the region in the latest quarter.

FedEx Corp.—Down 1.5%: The package-delivery company reported weaker-than-expected quarterly profits, though sales grew more than expected.

Newsletter Sign-up

Oracle Corp.—Down 3.7%: Oracle reported sales for the most recent quarter that were weaker than Wall Street expected, with revenue from cloud services disappointing some analysts.

Avon Products Inc.—Up 5.8%: Brazil’s

Natura Cosmeticos

recently approached Avon about a takeover, The Wall Street Journal reported.

Express Scripts Holding Co.—Down 0.5%: Shares of Express Scripts rose 3.7% Monday after the company and health insurer Cigna said late in the session the antitrust division of the U.S. Department of Justice cleared their pending merger.


—Down 5.4%: The auto-parts retailer missed sales expectations for its latest quarter and beat analysts’ estimates for earnings.

Tilray Inc.—Up 12%: The marijuana producer said the U.S. Drug Enforcement Administration has granted approval to import a


medical cannabis drug for a clinical trial at the University of California San Diego.

This is a version of the “Stocks to Watch” section of our Markets newsletter. To receive it every morning via email, click here.

Write to Amrith Ramkumar at